Life Sciences Consulting M&A Report [August 2025]

Unlock high-value insights into the dynamic and PE-fuelled Life Sciences consulting sector with the August 2025 update to our M&A report.

Explore the latest market growth drivers, deal trends, valuation benchmarks, and strategic opportunities shaping this fast-evolving ecosystem.

Download the report to gain deeper insights:

• The global Life Sciences consulting market is set to reach $52bn by 2025, growing at a 9.3% CAGR (2023–2030)
  
  
• 464 M&A deals since 2019 with ~80% led by Private Equity and activity concentrated in the US and Europe
  
  
• Valuations remain attractive: Private market median EV/EBITDA at 15.3x, well above public market levels (10.4x)
  
  
• Fragmented market with  ~80% of 2024 deals targeted firms with fewer than 100 employees, presenting consolidation opportunities
  
  
• Rising demand for advanced therapeutics, digital transformation, and regulatory expertise continues to fuel sector growth

Submit the form to download >> 

If you would like to further discuss the themes of this report, get in touch with the Equiteq team.